AVXL

JonesTrading analyst Soumit Roy maintained a Buy rating on Anavex Life Sciences (AVXL - Research Report) yesterday and set a price target of $80.00. The company's shares closed yesterday at $8.87.Roy covers the Healthcare sector, focusing on stocks such as Aeglea Biotherapeutics, Mirati Therapeutics, and Curis. According to TipRanks, Roy has an average return of 7.2% and a 33.75% success rate on recommended stocks. Currently, the analyst consensus on Anavex Life Sciences is a Strong Buy with an average price target of $49.25, implying a 455.24% upside from current levels. In a report released on November 28, BTIG also maintained a Buy rating on the stock with a $35.
https://www.tipranks.com/news/blurbs/anavex-life-sciences-avxl-receives-a-buy-from-jonestrading?utm_source=advfn.com&utm_medium=referral